KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) FCF Margin (2016 - 2025)

Ionis Pharmaceuticals (IONS) has 17 years of FCF Margin data on record, last reported at 2238.14% in Q4 2025.

  • For Q4 2025, FCF Margin rose 230065.0% year-over-year to 2238.14%; the TTM value through Dec 2025 reached 47.92%, up 6590.0%, while the annual FY2025 figure was 1558.69%, 163615.0% up from the prior year.
  • FCF Margin reached 2238.14% in Q4 2025 per IONS's latest filing, up from 87.23% in the prior quarter.
  • Across five years, FCF Margin topped out at 2238.14% in Q4 2025 and bottomed at 420380.0% in Q2 2024.
  • Average FCF Margin over 5 years is 21012.88%, with a median of 60.28% recorded in 2023.
  • Peak YoY movement for FCF Margin: plummeted -42032195bps in 2024, then surged 42043001bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 335.31% in 2021, then plummeted by -140bps to 134.53% in 2022, then skyrocketed by 108bps to 10.38% in 2023, then crashed by -702bps to 62.51% in 2024, then skyrocketed by 3680bps to 2238.14% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 2238.14% in Q4 2025, 87.23% in Q3 2025, and 50.01% in Q2 2025.